The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Interested in all sessions Cellular Therapy/Biotherapies? Then this is the package for you. We have also thrown in a couple of additional sessions you might also find interesting…
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…
CABP CE Eligible
Despite the need for diverse donors of blood, stem cells, and organs/tissues, such donors remain dramatically underrepresented in donor pools, across donation products.. This session will begin with a brief didactic component, where expert presenters (Dr. Warren Fingrut and Sylvia Okonofua) will outline the biological rationale underpinning the need for diverse donors across donation products, and the causes underlying the underrepresentation of diverse donors Specifically, the experts will explain unique barriers to donation impacting donors from marginalized groups (including racialized and LGBTQIA+ donors), highlight examples of structural racism and discrimination in donation policy (past and present) which need to be overcome, and present solutions to advance a more inclusive blood and transplant system for donors from underserved/ historically excluded populations. The experts will also present the case of a donor who is both racialized and LGBTQIA+, and guide the participants to consider the barriers that this donor might face with respect to their intersectional identity. The experts will especially emphasize the importance of partnership with patient/family/donor/community advocates to address disparities. Following these didactics, session participants will engage in facilitated, small group discussions, where they will discuss how to advance a more inclusive donation system for marginalized peoples. Each small group will focus on one of the following core themes: highlighting the need to prioritize inclusion, recognizing discrimination, understanding barriers to change, addressing disparities in collaboration with advocates, and building a culture to support inclusion. These small groups will explore how each of these themes relate to the practice of transfusion medicine not just with respect to donor recruitment but also in the clinical spheres. Additional experts in DEI in donation and transplantation will be invited as facilitators. Finally, the presenters (Dr. Warren Fingrut and Sylvia Okonofua) and the expert facilitators will form a panel, and will invite representatives of each breakout group to share a summary of their learnings for discussion with the panel.
Learning Objectives
Explain the need to prioritize inclusion of donors from marginalized population on donor pools across donation products.
Identify discrimination in donation policies affecting patients and donors from racialized/marginalized populations.
Identify barriers to changing policies and practices that are discriminatory or which otherwise negatively impact patients and donors from racialized/marginalized populations.
Employ a strategy to address disparities in collaboration with advocates from racialized/marginalized populations to advance health equity across donation products.
Design and promote a culture to support an inclusive donation system for patients, donors and the workforce.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM24-TU-03-O: Addressing Racial Disparities Across Donation Products for Marginalized Peoples (Enduring) Evaluation
A presentation of how one facility tackled a massive inventory reduction project to discard cell therapy products that had been in LN2 storage for 10 to 25 years…
The Biotherapies Spotlight Session will cover several diverse topics. The use of controlled incremental filtration microfluidics rather than monoclonal antibody selection systems to isolate B-cells from whole blood will be discussed…
This session will highlight advances in three areas of platelet research; stabilization methods through lyophilization, iPSC ex-vivo production, and synthetic nanoparticle technology are converging and can lead to long-lived platelet-based therapies targeted to address specific related pathologies…